Results 131 to 140 of about 19,917 (239)
Allosteric Regulation of Catalytic Activity: Escherichia coli Aspartate Transcarbamoylase versus Yeast Chorismate Mutase [PDF]
Kerstin Helmstaedt+2 more
openalex +1 more source
Abstract Soticlestat (TAK‐935) is a cholesterol 24‐hydroxylase inhibitor. A physiologically‐based pharmacokinetic model has been developed to predict potential soticlestat drug–drug interactions (DDIs) using the Simcyp v20 Population‐based Simulator and verified with data from single‐/multiple‐rising‐dose and clinical DDI studies.
Hongxia Jia+7 more
wiley +1 more source
Abstract The β2AR is a prototypical G protein‐coupled receptor (GPCR) known to orchestrate different cellular responses by the stimulation of specific signaling pathways. The best‐established signaling pathways for the β2AR are the canonical Gs pathway and the alternative β arrestin 2 (βarr2) pathway.
Emilio Y. Lucero‐Garcia Rojas+4 more
wiley +1 more source
Disorder driven allosteric control of protein activity
Studies of protein allostery increasingly reveal an involvement of the back and forth order-disorder transitions in this mechanism of protein activity regulation.
Wei-Ven Tee+2 more
doaj
Computational Studies of Enzymes for C−F Bond Degradation and Functionalization
Enzyme‐mediated strategies for C−F bond cleavage offer a promising solution for addressing the environmental challenges posed by the Forever Chemicals. This review discusses how computational approaches – including molecular docking, molecular dynamics, QM/MM, and bioinformatics – enhance the understanding of enzymatic degradation mechanisms, guiding ...
Kendra M. Cunningham+2 more
wiley +1 more source
The gdhB Gene of Pseudomonas aeruginosa Encodes an Arginine-Inducible NAD + -Dependent Glutamate Dehydrogenase Which Is Subject to Allosteric Regulation [PDF]
Chung‐Dar Lu, Ahmed T. Abdelal
openalex +1 more source
Oral small molecule inhibitors of tumor necrosis factor alpha (TNFα) are emerging as attractive therapeutic agents for the treatment of various autoimmune diseases. Balinatunfib (SAR441566), a novel oral inhibitor of tumor necrosis factor receptor 1 (TNFR1) signaling, changes the configuration of the soluble TNFα (sTNFα) trimer and prevents its ...
Nassr Nassr+12 more
wiley +1 more source
Structural basis for allosteric substrate specificity regulation in anaerobic ribonucleotide reductases [PDF]
Derek T. Logan+3 more
openalex +1 more source